Inmolecule NanotechXPAR:MLINA 6 Days Inventory is 2,372.50 as of Dec. 2024, which is 25% above its 10-year median of 1,892.18. GuruFocus rates XPAR:MLINA with a GF Score™ of 6/100. The stock has 2 warning signs investors should review. Among 638 Biotechnology companies, Inmolecule Nanotech ranks worse than 95.77% on this metric.
The historical rank and industry rank for Inmolecule Nanotech's Days Inventory or its related term are showing as below:
XPAR:MLINA'
s Days Inventory Range Over the Past 10 Years
Min: 1411.85 Med: 1892.18 Max: 2372.5
Current: 2372.5
During the past 2 years, Inmolecule Nanotech's highest Days Inventory was 2372.50. The lowest was 1411.85. And the median was 1892.18.
XPAR:MLINA's Days Inventory is ranked worse than 95.77% of 638
companies
in the Biotechnology industry
Industry Median: 183.875
vs XPAR:MLINA: 2372.50
Inmolecule Nanotech's Days Inventory
increased
from . 20 (0.00) to Dec. 2024 (2,372.50).
It might indicate that Inmolecule Nanotech's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inmolecule Nanotech's Inventory Turnover for the
six
months ended in Dec. 2024 was 0.15.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Inmolecule Nanotech's Inventory-to-Revenue for the
six
months ended in Dec. 2024 was 1.31.
Inmolecule Nanotech (XPAR:MLINA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Inmolecule Nanotech's Inventory Turnover for the
six
months ended in Dec. 2024 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Inmolecule Nanotech's Inventory to Revenue for the
six
months ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Inmolecule Nanotech Days Inventory Related Terms
Inmolecule Nanotech Days Inventory Historical Data
* Premium members only.
The historical data trend for Inmolecule Nanotech's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inmolecule Nanotech Days Inventory Chart
Inmolecule Nanotech Annual Data
Trend
Dec23
Dec24
Days Inventory
1,411.85
2,372.50
Inmolecule Nanotech Semi-Annual Data
Dec23
Dec24
Days Inventory
1,411.85
2,372.50
XPAR:MLINA vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Inmolecule Nanotech's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inmolecule Nanotech Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Inmolecule Nanotech's Days Inventory distribution charts can be found below:
* The bar in red indicates where Inmolecule Nanotech's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inmolecule Nanotech (XPAR:MLINA) has a Days Inventory of 2,372.50 as of Dec. 2024. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Inmolecule Nanotech and its competitors. This is 25% above median its historical median of 1,892.18. Over the past decade, Inmolecule Nanotech's Days Inventory has ranged from 1,411.85 to 2,372.50. According to the industry distribution chart, Inmolecule Nanotech ranks #611 out of 638 companies in the Biotechnology industry, placing it in the top 95.8%.
Is Inmolecule Nanotech's Days Inventory too high?
Inmolecule Nanotech's current Days Inventory of 2,372.50 is 25% above median its 10-year median of 1,892.18. Over the past 10 years, this metric has ranged from a low of 1,411.85 to a high of 2,372.50. The Biotechnology industry median Days Inventory is 183.88. Inmolecule Nanotech's value of 2,372.50 is 1190.3% above this industry median. Based on the distribution chart, Inmolecule Nanotech ranks #611 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Inmolecule Nanotech has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Inmolecule Nanotech's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Inmolecule Nanotech ranks #611 out of 638 companies for Days Inventory. This places Inmolecule Nanotech in the lower half of its industry. The industry median Days Inventory is 183.88. Inmolecule Nanotech's value of 2,372.50 is 1190.3% above this benchmark. Historically, Inmolecule Nanotech's own Days Inventory has ranged from 1,411.85 to 2,372.50 over the past decade. While the company's 10-year median is 1,892.18 vs. the industry median of 183.88, Inmolecule Nanotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Inmolecule Nanotech's current Days Inventory of 2,372.50 is 1190.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Inmolecule Nanotech and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inmolecule Nanotech's current Days Inventory is 2,372.50, which is 25% above median its own 10-year median of 1,892.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inmolecule Nanotech stock overvalued right now?
Inmolecule Nanotech (XPAR:MLINA) has a current Days Inventory of 2,372.50. The current Days Inventory is 2,372.50, which is 25% above median its 10-year median of 1,892.18 and 1190.3% above the Biotechnology industry median of 183.88. Inmolecule Nanotech's overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Inmolecule Nanotech (XPAR:MLINA), the current Days Inventory is 2,372.50 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLINA has been successfully added to your 